Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...
A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Measles is a serious, potentially deadly virus, but it can also impact someone's immunity even after they've recovered.
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery ...
MedPage Today on MSN2d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback